Breakfast Symposia

Date: Saturday 17 October (Day 2)
Time: 7:15am to 8:15am 
Duration: 1 hour

Real-world evidence is beginning to answer many of the questions clinicians and pregnant women have about maternal RSV immunisation. This session will explore emerging Australian and international data on vaccine effectiveness and safety, the impact on infant RSV hospitalisations, and what these findings mean for clinical practice and conversations in antenatal care.

Sponsored by Pfizer.